Ginkgo Bioworks, Pfizer announce multi-target RNA discovery collaboration

By NS Healthcare Staff Writer

28 Sep 23

Under the partnership, Pfizer will use Ginkgo's patented RNA technology to discover RNA-based drug candidates and in return,…

PharmaceuticalsDrug discovery

Deep Genomics launches BigRNA foundation model for RNA therapeutics

By NS Healthcare Staff Writer

28 Sep 23

BigRNA is designed to accurately predict the tissue-specific regulatory mechanisms of RNA expression and predict the binding sites…

PharmaceuticalsDrug discovery

Evozyne Announces $81m Financing Round to Advance Generative AI for Therapeutic Discovery and Drug Development

By NS Healthcare Staff Writer

28 Sep 23

New investor OrbiMed expects platform to reduce development time for novel treatments and therapeutic approaches

PharmaceuticalsDrug discovery

Italy’s Alfasigma to purchase Intercept Pharmaceuticals for $794m

By NS Healthcare Staff Writer

27 Sep 23

Intercept is engaged in developing and commercialising novel therapeutics for rare and serious liver diseases, and its acquisition…

PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates

Ionis’ olezarsen meets primary endpoint in Phase 3 FCS patient trial

By NS Healthcare Staff Writer

27 Sep 23

In the study, the results showed a statistically significant reduction in TG levels with the olezarsen 80 mg…

PharmaceuticalsClinical trials

UKHSA enters into new influenza pandemic vaccine deal with CSL Seqirus

By NS Healthcare Staff Writer

27 Sep 23

As per the agreement, CSL Seqirus will be on standby to produce more than 100 million registered influenza…

PharmaceuticalsClinical supplies and logistics

Merck’s MilliporeSigma opens two new mRNA manufacturing sites in Germany

By NS Healthcare Staff Writer

27 Sep 23

The contract testing, development and manufacturing organisation (CTDMO) will now provide integrated services for all key phases of…

PharmaceuticalsDrug discovery

WuXi Vaccines Launches its First Vaccines CDMO Site in China

By NS Healthcare Staff Writer

27 Sep 23

The DP facility is equipped with an automatic vial washing, sterilizing, filling and capping line, which can support…

PharmaceuticalsContract Manufacturing

Novo Nordisk, Valo partner to develop new treatments for cardiometabolic diseases

By NS Healthcare Staff Writer

26 Sep 23

Valo will receive an upfront payment and a potential near-term milestone payment, totalling $60m, and is eligible to…

PharmaceuticalsPartnerships and Licensing Agreements

Novartis radioligand therapy Lutathera demonstrated statistically significant and clinically meaningful progression-free survival in first line advanced gastroenteropancreatic neuroendocrine tumors (GEP-NETs)

By NS Healthcare Staff Writer

26 Sep 23

Phase III NETTER-2 trial met primary endpoint of improvement in progression-free survival (PFS) and key secondary endpoint of…

PharmaceuticalsClinical trials